Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2009
04/08/2009EP2043441A1 Fungicide hydroximoyl-tetrazole derivatives
04/08/2009EP1551830B1 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibators
04/08/2009EP1442026B1 Triazole derivatives as cyclooxygenase (cox) inhibitors
04/08/2009EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists
04/08/2009CN101405286A Hydantoin derivatives for the treatment of inflammatory disorders
04/08/2009CN101405282A Aurora kinase modulators and method of use
04/08/2009CN101405275A Triazolone derivative
04/08/2009CN101405270A Pyrazoles as 11-beta-HSD-1
04/08/2009CN101405263A Cannibinoid receptor modulators
04/08/2009CN101405259A Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative
04/08/2009CN101402630A Preparation of losartan
04/08/2009CN101402601A Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
04/08/2009CN101402554A 2- and 2,5-substituted phenylketo-enols
04/08/2009CN100475823C Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
04/08/2009CN100475792C Novel gamma-secretase inhibitors
04/08/2009CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/08/2009CN100475777C Amide type carboxamide derivative
04/07/2009US7514570 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
04/07/2009US7514569 Benzimidazolone compound
04/07/2009US7514562 Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain
04/07/2009US7514460 Benzazole analogues and uses thereof
04/07/2009US7514458 Heterocyclic-substituted benzamide derivatives, e.g., benzyl [2-(4-{1-[5-(5-tert-Butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazol-4-yl}-2-phenyl-2H-pyrazol-3-yl)-ethyl]-carbamate; inhibit production of cytokines; useful for treating chronic inflammatory disease
04/07/2009US7514447 e.g. [2-(4-Isopropyl-piperazin-1-yl)-benzooxazol-6-yl]-[5-(4-methoxy-phenyl)-pyrimidin-2-yl]-amine; C-kit kinase receptor or stem cell factor inhibitors; anticarcinogenic agents; veterinary medicine
04/07/2009US7514446 antineoplastic/antimitotic agents; inhibit proliferation of the cell; breast cancer, colon cancer, lung cancer, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma; Polo-like kinase inhibitors; 2-({5-nitro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid hydrochloride
04/07/2009US7514445 Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors)
04/07/2009US7514438 Melanin concentrating hormone receptor antagonist
04/07/2009US7514437 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs
04/07/2009US7514436 Antidiabetic agents; disease of glucose tolerance; insulin resistance; obesity; dyslipidemia; metabolic disorders; liver disorders; [4-(6-Phenethyloxy-pyridazin-3-yl)piperazin-1-yl]-(2-trifluoromethyl-phenyl)-methanone; stearoyl-CoA desaturase modulators
04/07/2009US7514430 Nitrogen compounds such as N-phenyl-N'-{(1R,2S)-2-[(2S)-2-benzyl-6-oxo-morpholin-4-yl-methyl]-cyclohexyl }-urea, used to control chemotactic cytokines, and administered for the prevention of asthma or allergies; inhibition of the migration of eosinophils
04/07/2009US7514428 Pesticidal 1-aryl-3-amidoxime-pyrazole derivatives
04/07/2009US7514422 To treat obesity, schizophrenia, anxiety, depression, alcoholism; using 3-benoazepine compounds like 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin); serotonin 2c receptor agonists
04/07/2009CA2463294C Inhibitors of human phosphatidyl-inositol 3-kinase delta
04/07/2009CA2393757C Cycloamine ccr5 receptor antagonists
04/07/2009CA2381243C 1-cycloalkylpyrazoyl-benzoyl derivatives
04/07/2009CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents
04/07/2009CA2352503C Il-5 inhibiting 6-azauracil derivatives
04/07/2009CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease
04/02/2009WO2009042907A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
04/02/2009WO2009042733A1 Solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate
04/02/2009WO2009041559A1 Indazole acrylic acid amide compound
04/02/2009WO2009041447A1 5-membered heterocyclic compound
04/02/2009WO2009040399A1 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
04/02/2009WO2009039859A1 Ring-substituted phenyl pyrrole aminoguanidine derivatives
04/02/2009WO2009039635A1 Methods of modulating neurotrophin-mediated activity
04/02/2009WO2009016227A3 Novel compounds
04/02/2009WO2009011880A3 Heterocyclic modulators of pkb
04/02/2009WO2008157537A3 Compositions and methods of use for treating or preventing lipid related disorders
04/02/2009WO2008124651A3 Nitro-imidazole hypoxia imaging agents
04/02/2009WO2008007930A9 Melanocortin receptor agonists
04/02/2009US20090088575 Process For Producing N,N'-Carbonyldiimidazole
04/02/2009US20090088571 Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
04/02/2009US20090088570 Organic electroluminescent device
04/02/2009US20090088490 Two-photon absorption recording material containing dye having polymerizable group
04/02/2009US20090088447 Solid forms of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use
04/02/2009US20090088431 Heteroaromatic Compounds as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase
04/02/2009US20090088428 (R)-3-(3,5-Dichloro-4'-morpholin-4-yl-biphenyl-4-ylmethyl)-1-(4,5,6,7-tetrahydro-1H-benzoimidazol-5-yl)-pyrrolidin-2-one for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome
04/02/2009US20090088422 4-imidazolin-2-one compounds
04/02/2009US20090088420 Compounds with hiv-1 integrase inhibitory activity and use thereof as anti-hiv/aids therapeutics
04/02/2009US20090088406 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
04/02/2009US20090088361 Cleaning agent for semiconductor device and cleaning method using the same
04/02/2009US20090087489 Imatinib compositions
04/02/2009US20090087409 Viral Polymerase Inhibitors
04/02/2009US20090087376 Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease
04/02/2009US20090085468 Aromatic amine derivatives and organic electroluminescence devices using the same
04/02/2009US20090084441 Dye-sensitized photoelectric conversion device
04/02/2009CA2700841A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
04/02/2009CA2700835A1 Solid forms of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use
04/02/2009CA2700113A1 Indazole acrylic acid amide compound
04/01/2009EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists
04/01/2009EP2042488A1 Matrix metalloproteinase inhibitors
04/01/2009EP2041120A1 Melanocortin receptor agonists
04/01/2009EP2041119A1 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof
04/01/2009EP2041118A1 Substituted heterocyclic compounds and methods of use
04/01/2009EP2041116A1 Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents
04/01/2009EP2041113A1 Novel pyridazine derivatives
04/01/2009EP2041085A1 Pyrrole derivatives and their methods of use
04/01/2009EP2041071A2 Biaryl compositions and methods for modulating a kinase cascade
04/01/2009EP2041067A2 Cxer4 antagonists including diazine and triazine structures for the treatment of medical disorders
04/01/2009EP2040546A2 Tyrosine kinase inhibitors
04/01/2009EP1828141A4 A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o
04/01/2009EP1673348B1 Benzoimidazole compounds
04/01/2009EP1653961A4 Inhibitors of akt activity
04/01/2009EP1506175B1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors
04/01/2009CN101400673A Heterobicyclic carboxamides as inhibitors for kinases
04/01/2009CN101400672A Pyrazolylquinazolinones as potassium channel openers
04/01/2009CN101400668A 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors
04/01/2009CN101397295A 2-dihydroindolemanone derivates as histone deacetylase inhibitor, preparation method and use thereof
04/01/2009CN101397294A N-substituted pyrrolidine derivates and uses thereof
04/01/2009CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products
04/01/2009CN100473648C 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
03/2009
03/31/2009US7511159 Azetidine ring compounds and drugs comprising the same
03/31/2009US7511152 6-(trifluoromethyl)-3,9,10,11-tetrahydro-8,10a-methanocyclohepta[1,2]indeno[4,5-d][1,2,3]triazol-7(8H)-one; uterine fibroid disease, hot flashes, urogenital disorders, inflammation; improved metabolic profile
03/31/2009US7511145 Bicyclic heteroaryl derivatives
03/31/2009US7511141 Piperidine-piperazine ligands for neurotransmitter receptors
03/31/2009US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders
03/31/2009US7511071 Thioamide derivatives as progesterone receptor modulators
03/31/2009US7511061 Triazoles as farnesyl transferase inhibitors
03/31/2009US7511047 Kinase inhibitors
03/31/2009US7511044 Vanilloid receptor ligands and their use in treatments
03/31/2009US7511042 1-[5-(5-tert-Butyl-2-methoxy-3-methylsulfamoyl-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazole-4-carboxylic acid (2,2-dimethyl-propyl)-amide; small molecule cytokine inhibitor; optimized efficacy, pharmacokinetic; antiinflammatory agent, osteoarthritis, asthma, gastrointestinal, respiratory disorder